Any views on why $MODG (assuming spin occurs) doesn’t work? On my figs, it’s trading at 1.3x Sales vs 2.3x for $GOLF and 2.4x for Taylormade. Seems wide, and v wide if you don’t agree that TopGolf equity should be marked at <$0.
Start pos on $BGSF. Staffing agency undergoing a strat review. Just sold Professional Services bix for $99M, leaving RemainCo (Property Mgmt) at ~$12M pro-forma EV or <1.5x normalized EBITDA of ~$8M. Mgmt is also cutting $9M costs into recovering demand environment. (1/3)
Property Mgmt segment has generated b/w $13-23M operating income historically (2019-24). Even assuming only 50% of $9M cost savings stick to RemainCo post-divestiture, we get ~$8M normalized EBITDA. At current valuation the discount seems too large. (2/3)
Granted, property mgmt isn't sexy. But consider: 1) they're cashed up from divestiture, so defensive if economy weakens 3) revenue inflection potential on rate cuts 4) strategic review ongoing = optionality. Risk/reward seems compelling at these levels. (3/3)
The action is increasing at Lantronixs $LTRX, with a.o. Chain of Lakes Investment reporting a 7.7% stake and pushing for Board changes in order to sell the company.
CoL believes that the company would be sold for ~$6 p/s (compared to $2.3 today).
Also to note the continued open market purchases from insiders.
Quick update as my attention has been elsewhere. Out of $SPOK for ~95% gain. Panic sold on the recent pop and left a buck on the table, but I wanted to avoid another round trip if this rally rolls over. Given its yield, I also think there is some underlying sensitivity to rates.
Took a minor bath (-20%) on $NEXS.L. Raw cheapness wasn't able to compensate for its highly vulnerable business model. Moving forward, I need to be far more considerate of HOW value gets unlocked, especially around (and in anticipation of) inflections.
Degenned into $RIG and $VNO calls which have paid of nicely. Still hold. Will wait out $SVT / $LUC given their revenue deferrals, but I think the underlying theses remain intact. Reduced $HWO.TO significantly. Am optimistic about $CULP given the recent perkiness and insider buys.
$SVT. Activist has pulled its nominations and ended the proxy contest. Calling for a strategic review of all assets, not just CPG instead. Note that ATG did ~$5M in EBIT pre-COVID and 737MAX accidents. Current MC of $30M.
Signet $SIG just quantified that LGD represent <15% of diamond sales…“the majority of our customers still prefer the rarity of buying a natural diamond”
Have started dabbling in a couple of biotech special sits and picked up some $MGTA. No strong view yet, but found it interesting that strat review advisor gets 1% of transaction value (if consummated) with min fee of $1.5M, implying value of $150M. ~$100M cash unrisked/~$47M MC
Quant based add: $CULP. At multi-yr lows. Mattress cos hammered from dumping by China et al COVID inventory overhang. $CULP suffering from deferred orders minimising op leverage. Mgnt hopeful of normalisation. MC $65M, 2/3 BV, $16M cash, no debt. Insider buying. Norm. NI ~$11M
Quick note (my first piece of writing in a while) on how I'm approaching the Nexus Infrastructure ($NEXS.L) tender offer: pointbarcapital.substack.com…